Particulars |
Company Name |
Bafna Pharmaceuticals Ltd |
Year End |
202303 |
Full Year |
Equity (Rs Cr.) |
23.66 |
B.V. Rs |
34.80 |
Sales Rs Cr. |
115.35 |
NP Rs Cr. |
11.14 |
NP Var% |
51.00 |
Div% |
0.00 |
CPS Rs |
7.00 |
EPS Rs |
4.70 |
Traded Value(Rs Lakhs) |
15.41 |
52 Week High |
126.00 |
52 Week Low |
77.00 |
Price BSE |
107.00 |
Price NSE |
104.00 |
Market Capital(Rs Cr.) |
252.48 |
P/C Ratio |
15.40 |
P/E Ratio |
22.70 |
Price Vs.BV |
3.07 |
|
Latest Quarter |
Year End |
202312 |
Sales Rs Cr. |
28.44 |
NP Rs Cr. |
-2.94 |
NP Var % |
-198.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
74.33 |
OPM |
8.50 |
NP |
3.85 |
NP Var% |
116.30 |
EPS |
4.76 |
PE |
22.42 |
|
|